Last reviewed · How we verify
NCT05714579: TAVHIS
Predictive Value of Pre-TAVI Infrahissian Conduction Time in the Occurrence of Complete Atrioventricular Block
NA trial testing Transcatheter Aortic Valve Implantation in Aortic Stenosis, Severe in 35 participants. Terminated before completion.
20 November 2024
Quick facts
| Lead sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 35 |
| Start date | 30 May 2023 |
| Primary completion | 20 November 2024 |
| Estimated completion | 20 November 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Transcatheter Aortic Valve Implantation
Conditions studied
- Aortic Stenosis, Severe — all drugs for Aortic Stenosis, Severe →
Sponsor
GCS Ramsay Santé pour l'Enseignement et la Recherche — full company profile →
Who can join
65 and older, any sex, with Aortic Stenosis, Severe. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is implantation of a Pacemaker at 30 days for occurrence of a high-grade conduction disorder per- or post-procedure (yes/no)
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05714579
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Transcatheter Aortic Valve Implantation
Trials testing the same drug.
- NCT07335900 — A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis · NA · recruiting
- NCT06375590 — NavIIcusp: Bicuspid Aortic Valve Stenosis With Navitor Platform International Experience · not yet recruiting
- NCT06212050 — Feasibility, Safety, and Effectiveness of the ACURATE neo2 Transcatheter Heart Valve for Severe Bicuspid Aortic Stenosis · enrolling by invitation
- NCT04864145 — Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation · NA · recruiting
- NCT04647864 — The Coronary AccEss After Tavi Registry - A Multicenter Prospective Registry for the Coronary Access After TAVI · unknown
Other recruiting trials for Aortic Stenosis, Severe
Currently open trials in the same condition.
- NCT06818110 — The CardioFit Trial: Exercise Training Before Aortic Valve Surgery · NA · active not recruiting
- NCT06596460 — A Study to Obtain Imaging Data in 40 Patients Having Transcatheter Aortic Valve Implantation (TAVI) · NA · recruiting
- NCT06377449 — Influence of Lung Ultrasonography on the Prognosis and Postoperative Outcomes in Cardiac Surgical Patients · NA · recruiting
- NCT06129799 — Exercise CMR in (p)LF-LG AS · recruiting
- NCT05751577 — TRanscatheter Aortic-Valve Implantation With or Without On-site Cardiac Surgery: the TRACS Trial · NA · active not recruiting
Other GCS Ramsay Santé pour l'Enseignement et la Recherche trials
Trials by the same sponsor.
- NCT07274657 — Superb Microvascular Imaging (SMI) and Two-Dimensional Endoscopic Ultrasound Guided Shear Wave Elastography (2D-SWE-EUS) · NA · not yet recruiting
- NCT07271277 — 3D MRI Assessment of Femoroacetabular Impingement in Patients With ACL Rupture - Exploratory Study · NA · not yet recruiting
- NCT07263997 — Assessment of a New Traction Device in Submucosal Dissection of Colorectal Lesions · NA · not yet recruiting
- NCT07249645 — Description of Return to Sport in Amateur Athletes Who Underwent Several Functional Tests (K-STARTS, Vertical Jumps and · NA · not yet recruiting
- NCT06678646 — Ultrasound-guided Release of the Median Nerve at the Elbow in Patients With Lacertus Syndrome · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05714579 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GCS Ramsay Santé pour l'Enseignement et la Recherche
- Last refreshed: 25 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05714579.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing